A detailed history of Logan Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Logan Capital Management Inc holds 110,324 shares of ABBV stock, worth $20 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
110,324
Previous 111,413 0.98%
Holding current value
$20 Million
Previous $20.3 Million 6.73%
% of portfolio
0.84%
Previous 0.9%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $168,566 - $196,847
-1,089 Reduced 0.98%
110,324 $18.9 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $979,376 - $1.12 Million
-6,128 Reduced 5.21%
111,413 $20.3 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $664,883 - $748,815
-4,832 Reduced 3.95%
117,541 $18.2 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $892,514 - $1.03 Million
6,681 Added 5.77%
122,373 $18.2 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $294,437 - $366,407
2,222 Added 1.96%
115,692 $15.6 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $668,965 - $770,414
-4,626 Reduced 3.92%
113,470 $18.1 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $4.13 Million - $4.95 Million
29,827 Added 33.79%
118,096 $19.1 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $34,089 - $39,098
-254 Reduced 0.29%
88,269 $11.8 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $1.63 Million - $2.07 Million
-11,809 Reduced 11.77%
88,523 $13.6 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $706,488 - $876,553
-5,353 Reduced 5.07%
100,332 $16.3 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $281,681 - $356,408
-2,622 Reduced 2.42%
105,685 $14.3 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $725,541 - $823,598
6,819 Added 6.72%
108,307 $11.7 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $14,308 - $15,940
136 Added 0.13%
101,488 $11.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $5,524 - $6,081
54 Added 0.05%
101,352 $11 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $895,129 - $1.21 Million
-11,121 Reduced 9.89%
101,298 $10.9 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $393,381 - $461,700
-4,579 Reduced 3.91%
112,419 $9.85 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $1.35 Million - $1.8 Million
-18,374 Reduced 13.57%
116,998 $11.5 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $270,771 - $410,522
-4,198 Reduced 3.01%
135,372 $10.3 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $476,490 - $596,191
-6,606 Reduced 4.52%
139,570 $12.4 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $36,843 - $44,296
-585 Reduced 0.4%
146,176 $11.1 Million
Q2 2019

Jul 24, 2019

BUY
$65.7 - $83.98 $1.3 Million - $1.66 Million
19,770 Added 15.57%
146,761 $10.7 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $93,416 - $109,946
1,211 Added 0.96%
126,991 $10.2 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $21,019 - $25,922
-270 Reduced 0.21%
125,780 $11.6 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $32,096 - $35,681
361 Added 0.29%
126,050 $11.9 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $171,210 - $202,580
1,907 Added 1.54%
125,689 $11.6 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $1.97 Million - $2.64 Million
-21,392 Reduced 14.74%
123,782 $11.7 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $921,751 - $1.01 Million
-10,292 Reduced 6.62%
145,174 $14 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $13,969 - $17,844
200 Added 0.13%
155,466 $13.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
155,266
155,266 $11.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $321B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.